Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Parkinson's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07097103
What this trial is testing

Parkinson's Research In Metagenomic Early Stage Biomarkers

Who this might be right for
Parkinson's Disease (PD)
IRCCS San Raffaele Roma 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT06015841
What this trial is testing

Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson's Disease

Who this might be right for
Parkinson DiseaseParkinson Disease 6, Early-Onset
AC Immune SA 150
Testing effectiveness (Phase 2)Looking for participantsNCT07265596
What this trial is testing

Early Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodromal Imaging)

Who this might be right for
Prodromal Parkinsons Disease
Michael J. Fox Foundation for Parkinson's Research 100
Testing effectiveness (Phase 2)Study completedNCT04867551
What this trial is testing

A Clinical Study of KDT-3594 in Japanese Patients With Early Parkinson's Disease

Who this might be right for
Parkinson Disease
Kissei Pharmaceutical Co., Ltd. 7
Large-scale testing (Phase 3)Study completedNCT04223193
What this trial is testing

Flexible-Dose Trial in Early Parkinson's Disease (PD)

Who this might be right for
Parkinson Disease
AbbVie 304
Large-scale testing (Phase 3)Study completedNCT03568968
What this trial is testing

Controlled Trial of Nicotinamide Riboside Supplementation in Early Parkinson's Disease

Who this might be right for
Parkinson Disease
Haukeland University Hospital 410
Early research (Phase 1)Study completedNCT04629404
What this trial is testing

A Clinical Trial to Evaluate the Pharmacodynamics/Pharmacokinetics and Safety of LY03003 in Early PD Patients

Who this might be right for
Parkinson Disease
Luye Pharma Group Ltd. 32
Not applicableWithdrawnNCT04536857
What this trial is testing

Detection of A-synuclein Aggregate as Biomarker in Diagnosing Parkinson's Disease at Early Stage by Using Protein Misfolding Cyclic Amplification (PMCA)

Who this might be right for
Parkinson's Disease
Huashan Hospital
Not applicableLooking for participantsNCT07619560
What this trial is testing

Developing Precision Microbiota-Based Cocktail Modification Therapy to Delay the Progression of Parkinson's Disease (PD) - Use Preclinical Human Trials to Confirm the Impact of the Optimal "Probiotic Y7, Tryptophan and Branched-chain Amino Acid" Cocktail Formula on Early Stage PD Patients

Who this might be right for
Parkinson Disease (PD)Gut MicrobiotaProbiotic
Taipei Medical University 120
Large-scale testing (Phase 3)Study completedNCT02337751
What this trial is testing

A Phase 3, Long-term, Extension Study of TVP-1012 (1 mg) in Early Parkinson's Disease Participants

Who this might be right for
Parkinson's Disease
Takeda 198
Large-scale testing (Phase 3)Study completedNCT00558025
What this trial is testing

Overnight Switch Trial From Pramipexole IR to Pramipexole ER in Patients With Early Parkinson Disease

Who this might be right for
Parkinson Disease
Boehringer Ingelheim 156
Not applicableStudy completedNCT03076307
What this trial is testing

DAT SPECT and Procedural Motor Skills in Parkinson's Disease

Who this might be right for
Parkinson Disease
University Hospital, Geneva 9
Early research (Phase 1)Looking for participantsNCT06608355
What this trial is testing

The Safety, Tolerability and Preliminary Efficacy of NouvNeu001 for Early-onset Parkinson's Disease

Who this might be right for
Early-onset Parkinson's Disease
iRegene Therapeutics Co., Ltd. 6
Not applicableStudy completedNCT01747655
What this trial is testing

A Post Marketing Observational Study of Activities of Daily Living in Advanced Parkinson's Disease Patients With Early Troublesome Motor Fluctuations and Treated With Duodopa - a Multi-country Study

Who this might be right for
Parkinson's Disease
AbbVie (prior sponsor, Abbott) 64
Large-scale testing (Phase 3)Looking for participantsNCT07174310
What this trial is testing

Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

Who this might be right for
Parkinson's Disease
Hoffmann-La Roche 900
Not applicableStudy completedNCT03645226
What this trial is testing

Gut Microbiota Across Early Stages of Synucleinopathy: From High-risk Relatives, REM Sleep Behavior Disorder to Early Parkinson's Disease

Who this might be right for
REM Sleep Behavior Disorder
Chinese University of Hong Kong 441
Testing effectiveness (Phase 2)Active Not RecruitingNCT03775096
What this trial is testing

Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease (Protocol 53136)

Who this might be right for
REM Sleep Behavior DisorderPre-motor Parkinson DiseaseSymptomatic Parkinson Disease
Michele Tagliati, MD 15
Not applicableStudy completedNCT03905954
What this trial is testing

The Impact of a Diagnosis of Parkinson's on Work

Who this might be right for
Parkinson Disease
Oxford Brookes University 696
Testing effectiveness (Phase 2)Study completedNCT04995081
What this trial is testing

Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD)

Who this might be right for
Parkinson Disease
Hope Biosciences Research Foundation 60
Not applicableEnded earlyNCT01547832
What this trial is testing

Mutations Associated With Parkinson s Disease

Who this might be right for
Parkinson's Disease
National Heart, Lung, and Blood Institute (NHLBI) 42
Next Page